Although some preliminary data MM cell lines and patient samples suggest overexpression of E2F1 as a potential mechanism of resistance (139), there is paucity of data on mechanism of resistance in MM to XPO1 inhibitors. This evidence concerns the gene E2F1 and Miyoshi myopathy.